Request Patient Education Materials

Understanding Commitment to Therapy
Patients need to understand that Visudyne is a multicourse therapy, with several treatments given over a period of time. Following the TAP Investigation protocol, therapy is typically administered once every 3 months as long as leakage appears on fluorescein angiography. In the 2-year TAP Investigation, Visudyne patients received an average of 3.4 treatments in the first year and 2.3 treatments the second year.¹ For each patient, follow-up evaluations with the treating physician are recommended at 3-month intervals to determine whether additional treatment is required.²

Appearing below are a number of official materials designed to help you prepare your patients for therapy with Visudyne.

Physician Counseling Tool

	Physician and/or staff members can use this comprehensive counseling tool to explain the AMD disease state, and discuss what a person with wet AMD can expect before, during, and after therapy with Visudyne

A Patient's Guide to AMD and Visudyne Therapy brochure

	A patient take-home, large-type brochure that details many aspects of AMD disease in patient-friendly language; this brochure is designed to help prepare your patients for what they can expect from Visudyne therapy and a list of Do's and Don'ts to follow during the course of Visudyne therapy

mySight Newsletters

	Four different newsletters feature answers to frequently asked questions, real-life success stories, practical advice for living with AMD, and sources for coping with low vision, as well as important safety information about Visudyne therapy mySight Newsletters 4 mySight Newsletters 3 mySight Newsletters 2 mySight Newsletters 1

mySight Therapy Diary

	The mySight Therapy Diary allows patients to track each visit, and to note whether therapy was received, track progress, and prepare for upcoming visits